Omrix Biopharmaceuticals, Inc. 4
4 · Omrix Biopharmaceuticals, Inc. · Filed Jan 7, 2008
Insider Transaction Report
Form 4
Burshtine Michael
Senior VP and CFO
Transactions
- Exercise/Conversion
Common Stock
2008-01-04$6.19/sh+32,665$202,196→ 32,665 total - Sale
Common Stock
2008-01-04$34.00/sh−32,665$1,110,610→ 0 total